Request Demo

Last update 08 May 2025

ADCY1

Last update 08 May 2025

Basic Info

Synonyms

AC1, ADCY1, adenylate cyclase 1

+ [9]

Introduction

Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. Mediates responses to increased cellular Ca(2+)/calmodulin levels (By similarity). May be involved in regulatory processes in the central nervous system. May play a role in memory and learning. Plays a role in the regulation of the circadian rhythm of daytime contrast sensitivity probably by modulating the rhythmic synthesis of cyclic AMP in the retina (By similarity).

Drugs associated with ADCY1

ST034307

Target

ADCY1

Mechanism

ADCY1 inhibitors

Active Org.

Purdue University

Originator Org.

Purdue University

Active Indication

Pain

Inactive Indication-

Drug Highest PhasePreclinical

First Approval Ctry. / Loc.-

First Approval Date20 Jan 1800

NB001

Target

ADCY1

Mechanism

ADCY1 inhibitors

Active Org.

Neologics Bioscience Inc.

Originator Org.

Neologics Bioscience Inc.

Active Indication

Solid tumor

Inactive Indication-

Drug Highest PhasePreclinical

First Approval Ctry. / Loc.-

First Approval Date20 Jan 1800

Peturadol

Target

ADCY1

Mechanism

ADCY1 inhibitors [+1]

Active Org.

University of Toronto

Originator Org.

Zhejiang Yongzhan Pharmaceutical Technology Co., Ltd

Active Indication

Neuralgia

Inactive Indication

Cancer Pain

Drug Highest PhasePreclinical

First Approval Ctry. / Loc.-

First Approval Date20 Jan 1800

Clinical Trials associated with ADCY1

CTR20180859

/ CompletedPhase 1

评估NB001在国人健康成年受试者中的安全性、耐受性、药代动力学和进食对药代动力学影响的I期临床试验

[Translation] Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and the effect of food on pharmacokinetics of NB001 in healthy adult Chinese subjects

主要目的：评估国人健康成年受试者单次和多次口服不同剂量NB001片的安全性、耐受性。次要目的：评估国人健康成年受试者单次和多次口服不同剂量NB001片的药代动力学特征；评估进食对口服NB001药代动力学特征的影响。

[Translation]

Primary objective: To evaluate the safety and tolerability of single and multiple oral administrations of different doses of NB001 tablets in healthy adult Chinese subjects. Secondary objective: To evaluate the pharmacokinetic characteristics of single and multiple oral administrations of different doses of NB001 tablets in healthy adult Chinese subjects; To evaluate the effect of food intake on the pharmacokinetic characteristics of oral NB001.

Start Date08 Jul 2019

Sponsor / Collaborator

Zhejiang Yongzhan Pharmaceutical Technology Co., Ltd

100 Clinical Results associated with ADCY1

100 Translational Medicine associated with ADCY1

0 Patents (Medical) associated with ADCY1

178

Literatures (Medical) associated with ADCY1

01 Sep 2025·Comparative Biochemistry and Physiology Part D: Genomics and Proteomics

Genome-wide identification of FTZ-F1 genes in Chlamys farreri and analysis of ChIP-seq-based binding sites and potential target genes

Article

Author: Han, Lianxue ; Fan, Qichao ; Liu, Peipei ; Pan, Luqing ; Miao, Jingjing ; Lei, Kexin ; Li, Xiuru ; Fu, Ruifeng

FTZ-F1 (Fushi tarazu factor-1) is a crucial member of the monomeric orphan nuclear receptor family, playing essential roles in reproductive development, steroidogenesis, and metabolism. However, studies on the function of FTZ-F1 and its target genes in bivalve mollusks remain limited. In this study, we conducted a genome-wide analysis of Chlamys farreri and identified two FTZ-F1 family members, designated as Cf FTZ-F1 and Cf FTZ-F1b. We characterized their sequence features, evolutionary relationships, and protein structures. To elucidate its potential regulatory roles, we employed chromatin immunoprecipitation sequencing (ChIP-seq) to identify potential target genes, revealing 22,570 binding peaks. Motif analysis identified three conserved motifs consistent with the known binding characteristics of FTZ-F1. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses indicated that the target genes associated with these motifs are primarily involved in phospholipid metabolism, carbohydrate metabolism, steroid hormone biosynthesis, and key signaling pathways such as the PI3K-Akt pathway. Notably, genes involved in steroid hormone biosynthesis (CYP17A1, Srd5a1), gonadal differentiation (DAX-1, Dmrta2), and metabolic regulation (fumA, Adcy1) were identified as putative targets, suggesting that Cf FTZ-F1 may play a crucial role in these physiological processes. ChIP-qPCR further validated the binding sites of several target genes. This study sheds insights into the regulatory roles of FTZ-F1 in C. farreri, particularly its potential involvement in steroidogenesis, gonadal development, and metabolic regulation, laying the foundation for future functional investigations.

01 Apr 2025·Clinical Gastroenterology and Hepatology

Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospective Multicenter Study

Article

Author: van Hooft, Jeanin E ; Mahoney, Douglas W ; Majumder, Shounak ; Kisiel, John B. ; Delgado, Adriana M. ; Foote, Patrick H. ; Burger, Kelli N. ; De La Fuente, Jaime ; Storm, Andrew C. ; Doering, Karen A ; Storm, Andrew C ; Gleeson, Ferga C ; Doering, Karen A. ; Berger, Calise K. ; Law, Ryan J. ; Chandrasekhara, Vinay ; Vargas Valls, Eric J ; Engels, Megan M.L. ; Kumbhari, Vivek ; Hoogenboom, Sanne A ; Abu Dayyeh, Barham K. ; Klatte, Derk C.F. ; Wallace, Michael B ; Gomez, Victoria ; Engels, Megan M L ; Wallace, Michael B. ; Burger, Kelli N ; Taylor, William R. ; Gandhi, Sonal ; Hoogenboom, Sanne A. ; Vargas Valls, Eric J. ; Sarwal, Dhruv ; Raimondo, Massimo ; Gleeson, Ferga C. ; van Hooft, Jeanin E. ; Rajan, Elizabeth ; Berger, Calise K ; Brahmbhatt, Bhaumik ; Law, Ryan J ; Abu Dayyeh, Barham K ; Lukens, Frank J ; Delgado, Adriana M ; Kisiel, John B ; Klatte, Derk C F ; Mahoney, Douglas W. ; Taylor, William R ; Bofill-Garcia, Aliana ; Lukens, Frank J. ; Foote, Patrick H

BACKGROUND AND AIMSIn previous studies, methylated DNA markers (MDMs) have been identified in pancreatic juice (PJ) for detecting pancreatic ductal adenocarcinoma (PDAC). In this prospective multicenter study, the sensitivity and specificity characteristics of this panel of PJ-MDMs was evaluated standalone and in combination with plasma carbohydrate antigen 19-9 (CA 19-9).METHODSPaired PJ and plasma were assayed from 88 biopsy-proven treatment-naïve PDAC cases and 134 controls (53 with normal pancreas, 23 with chronic pancreatitis [CP], 58 with intraductal papillary mucinous neoplasm). Bisulfite-converted DNA from buffered PJ was analyzed using long-probe quantitative amplified signal assay targeting 14 MDMs (NDRG4, BMP3, TBX15, C13orf18, PRKCB, CLEC11A, CD1D, ELMO1, IGF2BP1, RYR2, ADCY1, FER1L4, EMX1, and LRRC4) and a reference gene (methylated B3GALT6). Logistic regression was used to fit the previously identified 3-MDM PJ panel (FER1L4, C13orf18, and BMP3). Discrimination accuracy was summarized using area under the receiver-operating characteristic curve (AUROC) with corresponding 95% confidence interval (CI).RESULTSMethylated FER1L4 had the highest individual AUROC of 0.83 (95% CI, 0.78-0.89). The AUROC for the 3-MDM PJ + plasma CA 19-9 model (0.95; 95% CI, 0.92-0.98) was higher than both the 3-MDM PJ panel (0.87; 95% CI, 0.82-0.92)) and plasma CA 19-9 alone (0.91; 95% CI, 0.87-0.96) (P = .0002 and .0135, respectively). At a specificity of 88% (95% CI, 81%-93%), the sensitivity of this model was 89% (95% CI, 80%-94%) for all PDAC stages and 83% (95% CI, 64%-94%) for stage I/II PDAC.CONCLUSIONSA panel combining PJ-MDMs and plasma CA 19-9 discriminates PDAC from both healthy and disease control groups with high accuracy. This provides support for combining PJ and blood-based biomarkers for enhancing diagnostic sensitivity and successful early PDAC detection.

01 Mar 2025·Aging Cell

Epigenetic modulation rescues neurodevelopmental deficits in Syngap1^+/− mice

Article

Author: Singh, Akash Kumar ; Reddy, Neeharika M. N. ; Banerjee, Sourav ; Eswaramoorthy, M. ; Joshi, Ila ; Purushotham, Sushmitha S. ; Clement, James P. ; Kundu, Tapas K. ; Vasudevan, Madavan

AbstractSYNGAP1 is a Ras GTPase‐activating protein that plays a crucial role during brain development and in synaptic plasticity. Sporadic heterozygous mutations in SYNGAP1 affect social and emotional behaviour observed in intellectual disability (ID) and autism spectrum disorder (ASD). Although neurophysiological deficits have been extensively studied, the epigenetic landscape of SYNGAP1 mutation‐mediated intellectual disability is unexplored. Here, we have found that the p300/CBP specific acetylation marks of histones are significantly repressed in the hippocampus of adolescent Syngap1+/− mice. Additionally, we observed decreased dendritic branching of newly born DCX+ neurons in these mice, suggesting altered adult hippocampal neurogenesis. To establish the causal relationship of Syngap1+/− phenotype and the altered histone acetylation signature we have treated 2–4 months old Syngap1+/− mice with glucose‐derived carbon nanosphere (CSP) conjugated potent small molecule activator (TTK21) of p300/CBP lysine acetyltransferase (CSP‐TTK21). The enhancement of the p300/CBP specific acetylation marks of histones by CSP‐TTK21 restored synaptic functions, increased dendritic branching of DCX+ neurons, enables the capability to reorganise cortical circuits in response to change in the sensory stimuli, and improves behavioural measures in Syngap1+/− mice that are very closely comparable to wild type littermates. Further, hippocampal RNA‐Seq analysis of these mice revealed that the expression of many critical genes such as Adcy1, Ntrk3, Egr1, and Foxj1 which are key regulators of synaptic plasticity and neurogenesis and are well associated with ID/ASD reversed upon CSP‐TTK21 treatment. This study could be the first demonstration of the reversal of autistic behaviour and neural wiring upon the modulation of altered epigenetic modification(s).

Analysis

Perform a panoramic analysis of this field.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

ADCY1

Basic Info

Related

Analysis